Lisata Therapeutics Inc (LSTA)

[Viperciara]

Article from June 9th>>I had not seen the article before so posting now, I did like this statement from the article!

Mazzo said,

“Given that we acquired this asset approximately one year ago and, in the ensuing months, much of the external focus on our company was on our ischemic repair Phase 2 program, we believe that the market has not yet integrated the full potential of this mature immuno-therapy asset into the value of our company.”


To read full article go here>>>> http://californiastemcellreport.blogspot.com/2015/06/neostems-new-name-backed-by-29-million.html